Medicina News by Xagena

Neurology Newsletter by Xagena

13 febbraio 2020 XagenaMedicina Medicina

NeurologyOnline.net

–

NeurologyOnline.net – Neurology

–

Dopamine agonists Dopamine agonists can improve muscle control but cause worse …	Ataxia Mutations in the protein beta-III spectrin linked to …
Copaxone Search results for “Copaxone” … Sclerosis, provided evidence …	Daclizumab HYP Daclizumab HYP superior to Avonex in reducing annualized …
Brain aneurysm Search results for “Brain aneurysm” … risk of recurrence of brain …	Cervical dystonia Medication-refractory cervical dystonia: pallidal …
Daclizumab Daclizumab, a humanised monoclonal antibody …	Relapsing-remitting multiple MabCampath more effective than Rebif in relapsing-remitting …
Duopa Advanced Parkinson’s disease: Duopa is a treatment providing …	Discontinuation factors with … Discontinuation factors with use of … intestinal gel in patients with …
Altri risultati in neurologyonline.net » Acetylsalicylic acid Acute ischemic stroke Aducanumab Alemtuzumab Alpha-synuclein Alzheimer Alzheimer’s dementia Alzheimer’s disease Amytrophic lateral sclerosis Aneurysmal subarachnoid hemorrhage Apomorphine Aricept Aspirin Ataxia Atogepant Aubagio BACE1 inhibitor Biotin Brain aneurysm Carbidopa Carotid endarterectomy CCSVI Cerebral vasospasm Cervical dystonia CGRP receptor antagonist Cholinesterase inhibitors Cladribine Cluster headache Cocaine Cognitive decline Cognitive impairment Copaxone Daclizumab Daclizumab HYP Davunetide Deep brain stimulation Dementia Diabetes Dimethyl fumarate Donepezil Dopamine agonists Duchenne muscular dystrophy Duodopa Duopa Dystonia Ebixa Eculizumab Encephalitis Epilepsy Episodic migraine Epstein-Barr virus Exelon Exenatide Fingolimod Fremanezumab Frontotemporal dementia Fycompa Galantamine Galcanezumab Gilenya Glatiramer Glioblastoma Haemorrhagic stroke Head and neck squamous cell carcinoma Headache Huntington disease Idiopathic axonal polyneuropathy Insomnia Insulin resistance Interferon beta-1a Intracerebral hemorrhage Ischemic stroke Keppra Laquinimod Lasmiditan Lemtrada Levetiracetam Levodopa Levodopa-Carbidopa Levodopa-sparing therapy Lyrica MabThera MAOBI Melatonin Memantine Migraine Migraine with aura Mitoxantrone Monoamine oxidase type B inhibitors Multiple sclerosis Multiple system atrophy Myasthenia gravis Myelin Namenda Natalizumab Neurostimulation Novantrone Nuplazid Ocrelizumab Ofatumumab Ozanimod Parkinson’s disease PegInterferon Peginterferon beta-1a Pegylated interferon Pegylated interferon beta-1a Perampanel Pimavanserin Plegridy Ponesimod Pregabalin Primary progressive multiple sclerosis Progressive multifocal leukoencephalopathy Progressive supranuclear palsy Rebif Relapsing-remitting multiple sclerosis Reminyl Reyvow Rituximab Rivastigmine Safinamide Secondary progressive multiple sclerosis Simvastatin Solanezumab Soliris Spinal cord injury Spinal muscular atrophy Statin Stroke Tecfidera Temporal lobe epilepsy Teriflunomide TIA Tissue plasminogen activator Topamax Topiramate tPA Thrombectomy Tysabri Valproate Vascular dementia Verubecestat Xadago

Neurology, Neurology Newsletter by Xagena, Neurology Updates, Updates in Neurology